30 results on '"Ozguler, Y"'
Search Results
2. POS0814 OUTCOME OF VASCULAR INVOLVEMENT OF BEHÇET’S SYNDROME TREATED WITH INFLIXIMAB: A RETROSPECTIVE COHORT STUDY
3. POS1363 THE VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF BEHÇET’S SYNDROME OVERALL DAMAGE INDEX IN A RETROSPECTIVE COHORT
4. AB0635 Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis
5. AB1305 A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHÇET’S SYNDROME
6. POS0820 INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHÇET SYNDROME
7. POS0819 EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHÇET SYNDROME
8. POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET SYNDROME
9. AB0364 DO PATIENTS PARTICIPATING IN MEETINGS REPRESENT THE ACTUAL PATIENT POPULATION IN BEHÇET SYNDROME?
10. POS0814 DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHÇET SYNDROME
11. OP0032 ERAP1-MEDIATED IMMUNOGENICITY AND IMMUNE-PHENOTYPES IN HLA-B51+ BEHÇET’S DISEASE POINT TO PATHOGENIC CD8 T CELL EFFECTOR RESPONSES
12. FREQUENCY OF TUBERCULOSIS AND ASSOCIATED RISK FACTORS IN PATIENTS WITH BEHÇET'S SYNDROME.
13. GEOGRAPHICAL VARIABILITY OF ORGAN DAMAGE BURDEN IN A LARGE INTERNATIONAL MULTICENTER COHORT OF PATIENTS WITH BEHÇET'S SYNDROME: PRELIMINARY RESULTS OF THE PROBE STUDY.
14. VESSEL WALL INFLAMMATION DETECTED WITH SUPERB MICROVASCULAR IMAGING IN BEHÇET SYNDROME.
15. THU0572 Relationship between Menstruation and Symptoms of Behçet's Syndrome
16. AB0574 Fecal Calprotectin Level Looks Promising in Identifying Active Disease in behÇet's Syndrome Patients with Gastrointestinal Involvement: A Controlled and Pilot Study
17. SAT0363 A Systematic Literature Review on The Treatment of Skin, Mucosa and Joint Involvement of Behçet's Syndrome Informing The Eular Recommendations for The Management of Behçet's Syndrome
18. FRI0140 Restarting Biologics in Patients Who Developed Tuberculosis During Anti TNF-Alpha Treatment
19. AB0435 Malignancies in Rheumatoid Arthritis Patients Treated with TNF-Alpha Antagonists
20. FRI0281 Predictors of Quality of Life in Behçet's Syndrome
21. THU0284 Work Disability Over Time in Behçet's Syndrome Patients
22. SAT0140 How Correct are the Assumptions Made During the Development of Tuberculosis Screening Algorythms Before TNF-Alpha Antagonists?
23. TOCILIZUMAB TREATMENT IN SEVERE AND REFRACTORY BEHÇET'S SYNDROME: A CASE SERIES.
24. OCULAR AND PERIPHERAL BLOOD IMMUNE PHENOTYPES SUGGEST TRANSMIGRATION OF CD16+ MONOCYTES TO AN IMPORTANT EFFECTOR SITE IN BEHÇET'S DISEASE.
25. FRI0240 The clinical course of the acute deep vein thrombosis of the legs in behÇet’s syndrome
26. AB0483 Causes of hospitalisation in behcet’s syndrome over a ten-year period
27. AB0454 Suicidal ideation among patients with behcet’s syndrome
28. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
29. Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet's syndrome?
30. 2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.